{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:01:04Z","timestamp":1777510864459,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2016"],"award-info":[{"award-number":["RC 2016"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcmd.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T07:46:30Z","timestamp":1497685590000},"page":"148-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density"],"prefix":"10.1016","volume":"68","author":[{"given":"M.","family":"Baldini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Casirati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Ulivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cassinerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Khouri Chalouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Poggiali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Borin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Burghignoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"Cesana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcmd.2017.06.003_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur. J. Intern. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.bcmd.2017.06.003_bb0010","first-page":"106","article-title":"Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses","volume":"24","author":"Cox","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u2018simple\u2019 disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.berh.2011.10.015","article-title":"Gaucher disease and bone","volume":"25","author":"Mikosch","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00223-014-9923-y","article-title":"Gaucher disease and bone manifestations","volume":"95","author":"Marcucci","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"issue":"13","key":"10.1016\/j.bcmd.2017.06.003_bb0035","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ymgme.2011.08.004","article-title":"Therapeutic approaches to bone pathology in Gaucher disease: past, present and future","volume":"104","author":"Goker-Alpan","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2017.06.003_bb0045","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75","author":"Poll","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00774-004-0529-8","article-title":"Bone density changes with enzyme therapy for Gaucher disease","volume":"22","author":"Lebel","year":"2004","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1542\/peds.2007-2144","article-title":"Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1","volume":"122","author":"Andersson","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bcmd.2017.06.003_bb0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-005-0032-y","article-title":"Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy","volume":"28","author":"Ciana","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s12325-014-0174-0","article-title":"Management of bone disease in Gaucher disease type 1: clinical practice","volume":"31","author":"Giuffrida","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12020-014-0280-4","article-title":"Utility of the trabecular bone score (TBS) in secondary osteoporosis","volume":"47","author":"Ulivieri","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.bcmd.2017.06.003_bb0085","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00223-014-9919-7","article-title":"Spine bone texture assessed by trabecular bone score (TBS) to evaluate bone health in thalassemia major","volume":"95","author":"Baldini","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0095","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group","volume":"843","author":"WHO Study Group","year":"1994","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrendo.2012.217","article-title":"Advances in bone imaging for osteoporosis","volume":"9","author":"Adams","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0105","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00198-011-1824-6","article-title":"Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects","volume":"23","author":"Bousson","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0110","author":"Cormier"},{"key":"10.1016\/j.bcmd.2017.06.003_bb0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","article-title":"Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions. Part 2: trabecular bone score","volume":"18","author":"Silva","year":"2015","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0120","doi-asserted-by":"crossref","first-page":"E1283","DOI":"10.1210\/jc.2013-1195","article-title":"Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine","volume":"98","author":"Bouillon","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0125","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.bone.2007.03.007","article-title":"HSA: beyond BMD with DXA","volume":"41","author":"Bonnick","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bcmd.2017.06.003_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-007-0002-4","article-title":"Extending DXA beyond bone mineral density: understanding hip structure analysis","volume":"5","author":"Beck","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2008.12.001","article-title":"Patients with Gaucher disease living in England show a high prevalence of vitamin D insufficiency with correlation to osteodensitometry","volume":"96","author":"Mikosch","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0140","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar3111","article-title":"Bone events and evolution of biologic markers in Gaucher disease before and during treatment","volume":"12","author":"Stirnemann","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0145","doi-asserted-by":"crossref","DOI":"10.4081\/hr.2012.e21","article-title":"Bone turnover markers in patients with type 1 Gaucher disease","volume":"4","author":"Giuffrida","year":"2012","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0150","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jc.2011-0162","article-title":"Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease","volume":"96","author":"van Dussen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2017.06.003_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/bcmd.2001.0479","article-title":"Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease","volume":"28","author":"Drugan","year":"2002","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961730092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961730092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:05Z","timestamp":1761049985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961730092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":31,"alternative-id":["S107997961730092X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.06.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}